Regional intravenous gentamicin administration for treatment of postoperative tarso-metatarsal infection in a dog--a case report

The regional intravenous antibiotic administration has been used to achieve high local concentrations of antibiotics into the extremities. The goal of this case report was to describe a known, but not often used technique of local administration of antibiotics for treatment of acute soft tissue, joint or bone infection in a dog, which suffered from chronic renal failure. In a seven years old Great Dane tarso-metatarsal arthrodesis was performed and three days after surgery infection was obvious. Gentamicin-sensitive E. co i was found by antibiogram. A tourniquet was tightened on the affected limb and gentamicin was administered in a dosage of 0,5 mg/kg every twelve hours via an intravenous catheter placed in the saphenous vein. The therapy lasted for ten days and wound healing was progressive. Regional intravenous gentamicin administration was very effective in treating distal extremity infection.     

Clenbuterol and the horse revisited

Clenbuterol is a beta(2)-agonist and potent selective bronchodilator that is used to treat bronchospasm in the horse. The drug is normally administered to horses orally as a syrup formulation. Once absorbed into the systemic circulation, clenbuterol has the potential to cause many side effects, including a repartitioning effect and major alterations in cardiac and skeletal muscle function. Recent studies have also reported that clenbuterol can affect bone and the immune, endocrine and reproductive systems. A great deal of information has been published on the beneficial effects of short term therapeutic doses of clenbuterol on the equine respiratory system, although there is limited information about chronic administration, particularly since this has been associated with adverse physiological effects on other systems. This review summarizes the relevant understanding of clenbuterol for clinicians and horse owners who may administer this drug to pleasure and performance horses.     

Stakeholder position paper: poultry

There has been renewed concern in recent years about the use of antibiotics in food animal production and the potential risk it may pose to public health due to transfer of antibiotic resistance factors via the food supply. Although a legitimate concern, it bears reminding that this debate is not new. It has been ongoing for decades, yet there is still no documented case of human treatment failure due to antibiotic resistant bacteria acquired from USDA-inspected meat and poultry. This fact strongly suggests that the issue is not the imminent threat as has been portrayed by certain individuals or advocacy groups. The poultry industry as a whole has been using antibiotics responsibly for several decades, and there are strong beneficial arguments for their continued use. Responsible public policy demands a science-based approach be utilized in the decision making process before attempting to restrict or remove certain products due to overestimated risks. Part of this scientific review should include antibiotic use data, however this information has definite limitations and shortcomings which need to be understood before attempting to make any valid antibiotic resistance associations.     

Use of opioids for pain and anesthetic management in horses.

REGIONAL ADMINISTRATION: There is limited, but convincing, evidence that epidural administration of morphine and some other mu-agonist opioids consistently relieves regional pain in horses. In addition, this effect is not accompanied by notable undesirable effects. On the other hand, a clinically important analgesic action has not been demonstrated for similarly administered kappa-agonist opioids. There has been little objective data presented to support the analgesic effectiveness of intra-articularly administered opioids in horses. However, the evidence of local opioid receptors legitimately encourages work to substantiate the value of intra-articular opioid administration to relieve joint-associated pain in horses. SYSTEMIC ADMINISTRATION: So far, study results do not provide convincing, objective evidence to support the opinion that systemically administered opioids consistently and effectively relieve pain in horses. Given this lack of evidence, and considering that opioids stimulate locomotor and other forms of unwanted excitant behavior, reduce propulsive gastrointestinal motility, decrease alveolar ventilation (especially in association with general anesthesia), and require regulatory and practical considerations for abuse potential in both humans and horses, we conclude that routine, indiscriminate administration of opioids for pain relief in horses is not justified. Identification and focused, objective study of selective beneficial opioid actions to provide guidance for appropriate clinical use is long overdue.     

四环素类抗生素的环境行为研究进展

四环素类抗生素被广泛用于动物疾病的治疗,并长期以亚治疗剂量添加于动物饲料中用于动物疾病的预防和促进动物生长.由于四环素类抗生素大量使用使其在环境中普遍存在,并导致了细菌耐药性.研究表明某些四环素类抗生素在环境中具有一定的持久性,因此其在环境中行为引起了众多学者的关注.论文回顾了四环素类抗生素在环境中残留、迁移转化等方面...     

Residues of aminoglycoside antibiotics in eggs after medication of laying hens

1. The transfer of aminoglycoside antibiotics into eggs was determined separately from albumen, yolk or whole egg after oral administration of dihydrostreptomycin (DHS), neomycin and spectinomycin and after an intramuscular injection of DHS. Residues were assayed by an agar plate diffusion method in cylinders with a specific test organism for each antibiotic. 2. Only DHS, administered by the intramuscular route, led to detectable residues in eggs. The total amount of DHS excreted via the eggs represented 1% of the dose administered. 3. Residues in the whole egg were detected for 8 d.     

动物源食品中β-内酰胺类抗生素残留的检测现状

β-内酰胺类抗生素常用于畜牧业预防及控制动物感染性疾病。由于使用方法不当或不遵守休药期规定等原因,造成动物源食品中该类抗生素残留超标,给人类健康带来严重危害,因此需严格控制其在动物源食品中的残留。作者就目前常用的β-内酰胺类抗生素兽药残留的检测方法,包括微生物检测法、理化检测法及免疫分析法等作一简单介绍,分析各种方法的利弊,以期为动物源食品中药物残留检测技术的进一步开发提供参考。     

Antibiotic residues (bacterial inhibitory substances) in the milk of cows treated under label and extra-label conditions

The objectives of this study were to describe the depletion pattern of antibiotic residues (microbial inhibitory substances) from the milk of cows treated under field conditions of clinical disease and antibiotic administration, including both label and extra-label use, and to determine if the type of extra-label use, the route of administration, and the drug used were factors associated with prolonged shedding of residues in milk.

Milk samples from 138 cows, treated with a variety of antibiotic products on farms in southwestern Ontario in 1989 and 1990, were collected before treatment and for six days after cessation of treatment. Samples were tested for antibiotic residues with the Brilliant Black reduction test (BR-test) and the Bacillus stearothermophilus var calidolactis disc assay. In 13/138 (9.4%) of cow treatments, at least one milk sample was positive on both antibiotic residue tests after the label milk withholding time for the drug(s) used. In ten of these instances, the antibiotics were administered in extra-label fashion and in three the drugs were reportedly used according to label instructions. Extra-label use of antibiotics was significantly associated with increased risk of antibiotic residues in milk beyond the label withholding time. No significant differences in risk were observed among the various antibiotic products used in the study.

The farms involved in this study were selected on the basis of their proximity to our laboratory; therefore, the frequency of antibiotic residue detection after withholding times may not be indicative of the provincial or national situation. If farmers and veterinarians find themselves in a situation where extra-label use of an antibiotic is necessary, use of an alternative antibiotic that can be used at label dose and with a known withdrawal time may avoid a problem with residues.

     

Update on Seminal Vesiculitis in Stallions

Seminal vesiculitis in stallions reduces fertility and is often underdiagnosed. The most common cause is infection of seminal vesicles by bacteria capable of forming biofilms and a propensity for tissue persistence, for example, Pseudomonas aeruginosa. Achieving a clinical cure is challenging because of a high rate of recurrence. Systemic antibiotic therapy does not reach adequate therapeutic concentrations within the seminal vesicles; one alternative is endoscopy-guided, local antibiotic infusion into the gland lumen, with or without concurrent systemic antibiotics. Current diagnostic and therapeutic strategies for seminal vesiculitis are less than fully satisfactory, and several studies have been conducted to improve them. This review covers traditional and newer concepts regarding seminal vesiculitis, including diagnostic and treatment methods, management of stallions with this disorder, and authors’ experience with clinical cases.     

常用抗生素在鸡体内消除和鸡蛋中残留的规律研究进展

抗生素类药物在蛋鸡养殖过程中起着非常重要的作用,但一直以来抗生素的使用缺乏科学的指导,致使抗生素残留在动物性食品和环境中,给生态系统和人类健康带来了巨大的威胁。从21世纪初开始,全球各个国家和相关国际组织采取相应的措施控制动物性食品中抗生素的残留,并逐渐加大了监察力度。文章对蛋鸡饲养过程中常用抗生素在鸡体内的消除和在鸡蛋中的残留规律进行综述,并根据我国部分省市鸡蛋中抗生素残留现状,综述影响鸡蛋抗生素残留的因素,拟为抗生素的合理使用和休药期的制订提供参考。     

细菌耐药性扩散的机制

细菌耐药性是20世纪留给医学的难题。自然界中各种细菌广泛存在，相互联系；细菌具有多种在种内或种间进行自主转移或诱动转移的遗传因子如质粒、转座子、噬菌体等；质粒、转座子上还有募集和表达外源基因的整合子；在不断变化的环境中，细菌的质粒、转座子、噬菌体等通过接合、转化及转导等方式，相互间交换所携带的一些基因，可使菌群更好地适应环境。这是细菌在长期进化过程中所获得的生存本领。耐药基因最初可能起源于少数抗生素产生菌或细菌自身基因的随机突变，在抗生素广泛应用所形成的选择压力胁迫下，没有机会获得耐药基因的细菌不得不退出竞争，而有机会通过菌间交换获得耐药基因的细菌却能自如地生存、繁衍成为耐药亚群。在抗生素选择压力的持续胁迫下，交流一选择过程不断重复，于是便发展至今天如此严峻的细菌耐药局面。     

Nutrient–drug interactions in nutritional support

Abstract Objective: To review the types and potential consequences of diet/nutrient–drug interactions that can occur in patients receiving nutritional support. Data sources: A literature review was performed using Ovid multi‐database searching including Medline, Agricola and Biosis. Summary: Although very little information is currently available that pertains specifically to veterinary patients, we know from the human experience that food intake and diet composition can affect the absorption, distribution, metabolism, efficacy and toxicity of a drug. Conversely, certain drugs can alter the absorption of nutrients when administered in conjunction with food or act to antagonize nutrient metabolism or function. The different ways that incompatibility can arise between food or nutrients and drugs in patients receiving nutritional support and strategies for avoiding these problems are discussed. Conclusions: The consequences of diet/nutrient–drug interactions include decreased tolerance of nutritional support, loss of feeding access, decreased drug efficacy, nutrient malabsorption or malassimilation, and risk of drug overdosage. Therefore, when patients receiving nutritional support experience these types of complications, a review of the diet, route of nutritional support, drugs, and timing of feeding and medication administration are indicated.     

Chicken egg yolk antibodies(IgY) as non-antibiotic production enhancers for use in swine production:a review

In recent years,the use of in-feed antibiotics for growth and disease prevention in livestock production has been under severe scrutiny.The use and misuse of in-feed antibiotics has led to problems with drug residues in animal products and increased bacterial resistance.Chicken egg yolk antibodies(IgY) have attracted considerable attention as an alternative to antibiotics to maintain swine health and performance.Oral administration of IgY possesses many advantages over mammalian IgG such as cost-effectiveness,convenience and high yield.This review presents an overview of the potential to use IgY immunotherapy for the prevention and treatment of swine diarrhea diseases and speculates on the future of IgY technology.Included are a review of the potential applications of IgY in the control of enteric infections of either bacterial or viral origin such as enterotoxigenic Escherichia coli,Salmonella spp.,rotavirus,porcine transmissible gastroenteritis virus,and porcine epidemic diarrhea virus.Some potential obstacles to the adoption of IgY technology are also discussed.     

Animal consumption of antibiotics and chemotherapeutic drugs in Sweden during 1980, 1982 and 1984

The total animal consumption of antibiotic and chemotherapeutic drugs in Sweden during 1980, 1982 and 1984 has been studied. The study also included coccidiostatic, antiparasitic and antimycotic drugs. The total animal consumption during the years mentioned was 66.1, 68.8 and 72.6 tons of active substance, respectively, and the amount of antibacterial drugs for therapy was 28.7 (43.4%), 29.1 (42.5%) and 34.1 (47.0%) tons, respectively. Tetracycline, penicillin, sulphonamide and aminoglycoside were the four major groups of antibiotics used for therapy of bacterial infections in animals. The consumption was related to the metabolic bodyweights of animals which were the potential consumers. A comparison was also made with the corresponding human consumption during 1980. The data on antibiotic consumption can be divided by county and compared to the animal population and disease situation in each county. This study thus offers a good base for further investigations on different aspects of the use of antibiotics.     

Anaphylactic events observed within 4 h of ocular application of an antibiotic-containing ophthalmic preparation: 61 cats (1993-2010)

This study describes signalment, history, antibiotic administered, clinical signs observed, therapy, and outcome of anaphylactic events within 4 h following ophthalmic administration of an antibiotic to cats. Data came from survey responses (45 cats) or Federal Drug Administration reports (16 cats). Cat age (7 weeks-19 years), breed, and gender ranged widely. Most were healthy (87%) prior to anaphylaxis. Ophthalmic antibiotics commonly were administered for conjunctival (65%) or corneal (11%) disease, or ocular lubrication (7%) and contained bacitracin, neomycin, and polymyxin B (44%), or oxytetracycline and polymyxin B (21%). Polymyxin B was present in all cases. Vaccines or other drugs were also administered to 51% of cats. In 56% cases, anaphylaxis occurred within 10 min of drug application. Most (82%) cats survived. Although a causal association was not proved, ophthalmic antibiotic administration preceded anaphylaxis in all cats. Like other drugs, ophthalmic antibiotics should be used only when indicated.     

Treatment of clinical mastitis. Using antimicrobial susceptibility profiles for treatment decisions.

Antibiotic susceptibility of clinical mastitis pathogens has traditionally been determined using the agar diffusion method that was designed to reflect the antibiotic concentration in serum and interstitial fluid of human patients after receiving oral or intravenous administration. The validity of applying agar diffusion susceptibility breakpoints derived from humans to the treatment of bovine mastitis has not been established and is extremely questionable because (1) bovine milk pH and electrolyte, fat, protein, and leukocyte concentrations, growth factor composition, and pharmacokinetic profiles are different than those for human plasma and (2) human bacterial pathogens are often different from bovine mastitis pathogens. Also, antibiotics are distributed unevenly in an inflamed gland, and high antibiotic concentrations can alter neutrophil morphology or function in vitro and thereby inhibit bacterial clearance in vivo. The current cost of antibiotic susceptibility testing is $12 to $20 per test. Because the dairy industry is economically driven, any diagnostic test should be validated, have appropriate sensitivity and specificity, and have an acceptable economic return on the cost of testing before it can be routinely recommended. In the authors' opinion, antimicrobial susceptibility testing of mastitis pathogens has not been adequately validated for most mastitis pathogens and antibiotics; therefore, the authors do not currently recommend the use of susceptibility testing to guide treatment decisions for individual cows. Additional research is needed to further define the role, if any, that antimicrobial susceptibility testing should play in the treatment of clinical mastitis.     

Antibiotic use and resistance in animal farming: a quantitative and qualitative study on knowledge and practices among farmers in Khartoum, Sudan

Antibiotic resistance is a major emerging global public health threat. Farmers in the Khartoum state are believed to misuse antibiotics in animal farming leading to daily exposure to resistant bacteria and antibiotic residues. Hence, farmers are at potential risk exposure to bacteria, zoonotic infection and toxicity. We hypothesized that farmers' misuse of antibiotics could be due to their ignorance of the importance of optimal use of antibiotics, the potential health hazards and the economical waste associated with antibiotic misuse practices. In the present study, we investigated knowledge and practices among farmers regarding antibiotic use and resistance. For this purpose, a cross-sectional study was conducted in Khartoum state where data were collected from 81 farmers using structured interviews. Data were analysed both quantitatively and qualitatively. Fifty-two per cent of farmers were uneducated or had studied for < 6 years. The majority reported antibiotic use for treatment and prevention while only 5% stated use for growth promotion. Antibiotic group treatment for both sick and healthy animals was commonly practiced among most farmers. The most commonly used group of antibiotics was the quinolones, which was reported by one-third. Only 30% of the farmers had heard of antibiotic resistance and provided their definition. Almost half were not aware of the commonly transferred zoonotic infections between humans and animals. The farmers consume 1-2 meals/day from their own farm products. A significant association between low education, poor knowledge of farmers on antibiotic use, antibiotic resistance and zoonotic infections was found. This association may play a vital role in the present practiced misuse of antibiotics. Our findings on farmers' practices could be used as baseline information in defining the gaps related to antibiotic use and resistance in animal farming in Sudan. It can thus serve as a foundation for future interventions.     

兽药环境风险评估研究进展

随着畜禽集约化养殖数量增加,兽药被广泛用于治疗疾病或作为促生长剂添加到动物饲料中,中国2010-2017年兽用抗菌药的销售量从31 500 t增长到56 800 t。兽药的不合理使用、畜禽养殖过程中废弃物处理不当以及药物经过动物机体代谢后以原形药或代谢物随粪尿排出体外是兽药造成环境污染的主要原因。兽药进入环境后发生迁移转化造成了严重危害,包括抗生素耐药菌或耐药基因的产生、兽药在动植物源性食品和饮用水中的暴露间接影响人类健康、对非靶标动物的生态毒性等。作者就兽药在环境中的暴露、转归及对生态环境的主要影响进行了论述,并对药物的环境风险评估的重要性进行了阐述,针对降低兽药环境风险的措施提出了建议,以引起人们对兽药环境风险评估的关注和重视。     

Potential impacts of antibiotic use in poultry production

The ways in which antibiotics are used in poultry production have changed considerably during the past decade, mainly because of concerns about potential negative human health consequences caused by these uses. Human health improvements directly attributable to these antibiotic-use changes are difficult to demonstrate. Given that some antibiotics will continue to be used in the poultry industry, methods are needed for estimating the causal relationship between these antibiotic uses and actual animal and human health impacts. This is a challenging task because of the numerous factors that are able to select for the emergence, dissemination, and persistence of antibiotic resistance. Managing the potential impacts of antibiotic use in poultry requires more than a simple estimation of the risks that can be attributed to the use of antibiotics in poultry. Risk models and empirical studies that evaluate interventions that are capable of minimizing the negative consequences associated with specific antibiotic uses are desperately needed.     

Chicken egg yolk antibodies (IgY) as non-antibiotic production enhancers for use in swine production: a review

In recent years, the use of in-feed antibiotics for growth and disease prevention in livestock production has been under severe scrutiny. The use and misuse of in-feed antibiotics has led to problems with drug residues in animal products and increased bacterial resistance. Chicken egg yolk antibodies (IgY) have attracted considerable attention as an alternative to antibiotics to maintain swine health and performance. Oral administration of IgY possesses many advantages over mammalian IgG such as cost-effectiveness, convenience and high yield. This review presents an overview of the potential to use IgY immunotherapy for the prevention and treatment of swine diarrhea diseases and speculates on the future of IgY technology. Included are a review of the potential applications of IgY in the control of enteric infections of either bacterial or viral origin such as enterotoxigenic Escherichia coli, Salmonella spp., rotavirus, porcine transmissible gastroenteritis virus, and porcine epidemic diarrhea virus. Some potential obstacles to the adoption of IgY technology are also discussed.